Specific agonists for neurokinin B receptors

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Neuroscience

Background:

• Neurokinin B (NKB) is a key neuropeptide involved in various physiological processes.
• Developing selective receptor agonists is crucial for therapeutic applications.
• The NKB-(4-10) peptide sequence serves as a basis for drug discovery.

Purpose of the Study:

• To synthesize and evaluate analogues of the NKB-(4-10) peptide.
• To identify selective agonists for the neurokinin B receptor type.
• To understand structure-activity relationships for NKB receptor ligands.

Main Methods:

• Preparation of a series of NKB-(4-10) analogues.
• Pharmacological testing using dog carotid artery, rabbit pulmonary artery, and rat portal vein assays.
• Evaluation of receptor affinity for substance P (SP), neurokinin A (NKA), and neurokinin B (NKB).

Main Results:

• Replacement of Valine at position 7 with MePhe significantly increased NKB receptor affinity.
• The [MePhe7]NKB-(4-10) analogue exhibited marked selectivity for the NKB receptor.
• This analogue was inactive at NKA receptors and a weak agonist at SP receptors.

Conclusions:

• The [MePhe7]NKB-(4-10) analogue represents a highly selective NKB receptor agonist.
• The observed selectivity is likely due to conformational changes in the peptide rather than protection from metabolism.
• This finding advances the development of targeted therapeutics for NKB-mediated pathways.